US Broker Ratings

Dr. Reddy’s Laboratories Ltd (RDY): Investor Outlook on Growth Potential and Analyst Consensus

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a stalwart in the healthcare sector, remains a focal point for investors due to its robust position in the specialty and generic drug manufacturing..

Ascendis Pharma A/S (ASND) Stock Analysis: A 23.69% Upside Powered by Robust Revenue Growth

For investors seeking exposure to the dynamic biotechnology sector, Ascendis Pharma A/S (NASDAQ: ASND) presents a compelling opportunity. With a market capitalization of $12.21 billion and a focus on innovative..

HealthEquity, Inc. (HQY): Analyst Consensus Reveals 28.76% Potential Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the health information services industry, has been catching the eye of investors with its robust growth prospects and a compelling potential upside..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Unveiling a 36.67% Upside Potential

Investors eyeing the healthcare sector might find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) an intriguing prospect, particularly given its robust potential for growth. With a market capitalization of $8.35 billion, Jazz..

United Therapeutics Corporation (UTHR) Stock Analysis: Strong Buy Ratings and 14.82% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, particularly within the drug manufacturers’ industry specializing in both specialty and generic drugs. With a market capitalization of $19.18..

DaVita Inc. (DVA) Stock Report: Examining the 21% Potential Upside for Investors

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector, specifically within the medical care facilities industry, has garnered attention with its robust potential for growth and strategic positioning...

argenx SE (ARGX) Stock Analysis: Exploring the 12.12% Potential Upside in Biotech Innovation

argenx SE (NASDAQ: ARGX), a dynamic player in the biotechnology sector, continues to capture investor attention with its promising pipeline and significant market presence. As a commercial-stage biopharma company, argenx..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 7.74% Potential Upside for Investors

Doximity, Inc. (NYSE: DOCS) has positioned itself as a formidable player within the healthcare sector, specializing in health information services. With a market capitalization of $12.36 billion, Doximity has carved..

ResMed Inc. (RMD) Stock Analysis: Unveiling an 18.87% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a titan in the healthcare sector specializing in medical instruments and supplies, presents an intriguing prospect for investors seeking growth in the medical device industry. With..

Genmab A/S (GMAB) Stock Analysis: Evaluating a Promising 31.47% Upside in Biotechnology

Genmab A/S (NASDAQ: GMAB), a Danish biotechnology powerhouse, has captured the attention of investors with its robust pipeline of antibody-based products targeting cancer and other diseases. With a market capitalization..

Chemed Corp (CHE) Stock Analysis: Healthcare Giant with a Promising 34% Upside Potential

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, is making waves in the investment community with its compelling growth potential and robust operational framework. With a market..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating Healthcare Prospects with a 21.98% Potential Upside

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, presents an intriguing opportunity for investors seeking exposure to medical devices and health technology. Based in the Netherlands, Philips..

Takeda Pharmaceutical (TAK) Stock Analysis: Unpacking a Potential 31.94% Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust portfolio and strategic collaborations. As a leader in..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 21% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a dominant player in the healthcare sector, is known for its extensive portfolio of generic medicines and biopharmaceutical products. Based in Israel, Teva operates globally,..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..

Universal Health Services, Inc. (UHS) Stock Analysis: Insights into a Potential 11.73% Upside

Universal Health Services, Inc. (UHS), a prominent player in the healthcare sector, stands out with its diversified portfolio of acute care hospitals, outpatient facilities, and behavioral health services. Headquartered in..

Cooper Companies, Inc. (COO) Stock Analysis: Investor Outlook Reveals 18.72% Potential Upside

The Cooper Companies, Inc. (NYSE: COO) stands as a prominent player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $13.9 billion, Cooper Companies..

Labcorp Holdings Inc. (LH) – Investor Outlook: Analyzing a Potential 17.78% Upside

Labcorp Holdings Inc. (NYSE: LH) is a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Burlington, North Carolina, Labcorp continues to make strides..

Viatris Inc. (VTRS) Stock Analysis: Exploring the 15.83% Potential Upside in a Challenging Market

Viatris Inc. (VTRS), a prominent player in the healthcare sector, has been the subject of investor scrutiny as it navigates a complex landscape of opportunities and challenges. With a market..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 66% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) is a promising player in the biotechnology sector, specializing in innovative therapies that aim to improve the quality of life for patients and caregivers alike...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds